Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Peapack Gladstone Financial Corp

Peapack Gladstone Financial Corp increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,476 shares of the medical equipment provider’s stock after purchasing an additional 391 shares during the period. Peapack Gladstone Financial Corp’s holdings in Intuitive Surgical were worth $7,034,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $28,000. Hurley Capital LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth $28,000. Finally, Summit Securities Group LLC acquired a new position in Intuitive Surgical during the fourth quarter valued at $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 in the last 90 days. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of recent research reports. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Leerink Partners boosted their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Finally, Truist Financial cut their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a report on Monday, March 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $451.58 on Monday. The stock has a 50 day moving average price of $545.18 and a 200 day moving average price of $533.00. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a market capitalization of $160.84 billion, a price-to-earnings ratio of 70.45, a PEG ratio of 5.85 and a beta of 1.55.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.